75000 - Document - Document and Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
75010 - Statement - Consolidated Balance Sheets
link:presentationLink
link:calculationLink
link:definitionLink
75020 - Statement - Consolidated Balance Sheets (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75030 - Statement - Consolidated Statements of Operations
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - Consolidated Statements of Stockholders' Equity
link:presentationLink
link:calculationLink
link:definitionLink
75050 - Statement - Consolidated Statements of Cash Flows
link:presentationLink
link:calculationLink
link:definitionLink
995455 - Disclosure - Nature of Business and Basis of Presentation
link:presentationLink
link:calculationLink
link:definitionLink
995465 - Disclosure - Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995475 - Disclosure - Accounts Receivable, net
link:presentationLink
link:calculationLink
link:definitionLink
995485 - Disclosure - Inventory
link:presentationLink
link:calculationLink
link:definitionLink
995495 - Disclosure - Intangible Asset
link:presentationLink
link:calculationLink
link:definitionLink
995505 - Disclosure - Fair Value of Financial Instruments
link:presentationLink
link:calculationLink
link:definitionLink
995515 - Disclosure - Accrued Expenses and Other Current Liabilities
link:presentationLink
link:calculationLink
link:definitionLink
995525 - Disclosure - Loan and Security Agreement
link:presentationLink
link:calculationLink
link:definitionLink
995535 - Disclosure - Commitments and Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
995545 - Disclosure - Stockholders' Equity
link:presentationLink
link:calculationLink
link:definitionLink
995555 - Disclosure - Warrants
link:presentationLink
link:calculationLink
link:definitionLink
995565 - Disclosure - Net Loss per Common Share
link:presentationLink
link:calculationLink
link:definitionLink
995575 - Disclosure - Revenues
link:presentationLink
link:calculationLink
link:definitionLink
995585 - Disclosure - License Agreements
link:presentationLink
link:calculationLink
link:definitionLink
995595 - Disclosure - Acquisitions
link:presentationLink
link:calculationLink
link:definitionLink
995605 - Disclosure - Royalty Agreements
link:presentationLink
link:calculationLink
link:definitionLink
995615 - Disclosure - Income Taxes
link:presentationLink
link:calculationLink
link:definitionLink
995625 - Disclosure - Related Party Transactions
link:presentationLink
link:calculationLink
link:definitionLink
995635 - Disclosure - Segment Information
link:presentationLink
link:calculationLink
link:definitionLink
995645 - Disclosure - Summary of Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995655 - Disclosure - Accounts Receivable, net (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995665 - Disclosure - Inventory (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995675 - Disclosure - Intangible Asset (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995685 - Disclosure - Fair Value of Financial Instruments (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995695 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995705 - Disclosure - Loan and Security Agreement (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995715 - Disclosure - Commitments and Contingencies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995725 - Disclosure - Stockholders' Equity (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995735 - Disclosure - Warrants (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995745 - Disclosure - Net Loss per Common Share (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995755 - Disclosure - Revenues (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995765 - Disclosure - Income Taxes (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995775 - Disclosure - Segment Information (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995785 - Disclosure - Nature of Business and Basis of Presentation - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995795 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995805 - Disclosure - Accounts Receivable, net - Schedule of Accounts Receivable, Net (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995815 - Disclosure - Inventory - Schedule of Inventory (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995825 - Disclosure - Inventory - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995835 - Disclosure - Inventory - Summary of Balance Sheet Classification of Inventory (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995845 - Disclosure - Intangible Asset - Schedule of Carrying Amount of Intangible Asset (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995855 - Disclosure - Intangible Asset - Schedule of Finite Lived Intangible Assets Future Amortization Expenses (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995865 - Disclosure - Fair Value of Financial Instruments - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995875 - Disclosure - Fair Value of Financial Instruments - Schedule of Fair Value of Financial Instruments Measured on Recurring Basis (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995885 - Disclosure - Fair Value of Financial Instruments - Schedule of Changes in Fair Value of Contingent Consideration Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995895 - Disclosure - Fair Value of Financial Instruments - Schedule of Fair Value Measurements of Contingent Consideration Recurring Include Significant Unobservable Inputs (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995905 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995915 - Disclosure - Loan and Security Agreement - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995925 - Disclosure - Loan and Security Agreement - Schedule of Outstanding Debt and Unamortized Debt Discount Balances (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995935 - Disclosure - Loan and Security Agreement - Summary of Interest Expense and Amortization of Final Payment Fee, and Amortization of Debt Discount Related to Issuance Costs and Warrants (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995945 - Disclosure - Loan and Security Agreement - Schedule of Principal Payments (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995955 - Disclosure - Commitments and Contingencies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995965 - Disclosure - Commitments and Contingencies - Schedule of Lease Expense (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995975 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments of Leases (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995985 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments of Leases (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
995995 - Disclosure - Stockholders' Equity - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996005 - Disclosure - Stockholders' Equity - Summary of Stock Option Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996015 - Disclosure - Stockholders' Equity - Schedule of RSU and PSU Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996025 - Disclosure - Stockholders' Equity - Schedule of Stock-Based Compensation Expense Recognized (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996025 - Disclosure - Stockholders' Equity - Schedule of Stock-Based Compensation Expense Recognized (Details) [Default]
link:presentationLink
link:calculationLink
link:definitionLink
996035 - Disclosure - Warrants - Schedule of Warrant Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996045 - Disclosure - Warrants - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996055 - Disclosure - Net Loss per Common Share - Computation of Basic and Diluted Net Loss per Common Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996065 - Disclosure - Net Loss per Common Share - Potentially Dilutive Securities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996075 - Disclosure - Revenues - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996085 - Disclosure - Revenues - Schedule of Disaggregation of Product Sales (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996095 - Disclosure - License Agreements - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996105 - Disclosure - Acquisitions - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996115 - Disclosure - Royalty Agreements - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996125 - Disclosure - Income Taxes - Schedule of Loss Before Income Taxes and Effective Tax Rates (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996135 - Disclosure - Income Taxes - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996145 - Disclosure - Related Party Transactions - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996155 - Disclosure - Segment Information - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996165 - Disclosure - Segment Information - Schedule of the Reportable Segment and Includes the Reconciliation to Consolidated Net Loss (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996175 - Disclosure - Segment Information - Schedule of the Reportable Segment and Includes the Reconciliation to Consolidated Net Loss (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
Line of Credit Facility [Line Items]
Line Of Credit Facility [Line Items]
Related Party Transaction [Table]
Schedule Of Related Party Transactions By Related Party [Table]
Warrants
Warrants And Rights Note Disclosure [Text Block]
The entire disclosure for warrants and rights.
Scenario [Axis]
Scenario
Schedule of Accrued Liabilities [Table Text Block]
Schedule of Accrued Expenses and Other Current Liabilities
Preferred Stock, Shares Issued
Preferred stock, shares issued
Preferred Stock, Shares Issued, Total
Present value of operating lease liabilities
Operating Lease, Liability, Total
Operating lease liability
Lease liability
Super Senior Revolving Credit Facility
Super Senior Revolving Credit Facility [Member]
Super senior revolving credit facility.
Interest Expense, Operating and Nonoperating
Interest Expense, Operating and Nonoperating, Total
Consolidated interest expense
Fair value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Common Stock Fair Value
Fair value of common stock
Share-based compensation arrangement by share-based payment award options forfeitures or canceled in period.
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures Or Canceled in Period
Number of shares, Forfeited/Canceled
Number of shares, Forfeited/Canceled
Long-Term Debt, Maturity, Year Three
2029
Debt Instrument, Basis Spread on Variable Rate
Interest rate basis
Weighted average common shares outstanding, diluted
Weighted Average Number of Shares Outstanding, Diluted
Weighted Average Number of Shares Outstanding, Diluted, Total
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Stock-based compensation
APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total
Lessee, Operating Lease, Term of Contract
Operating lease, lease term
Minimum
Minimum
Long-Term Debt, Maturity, Year Two
2028
Private Placement
Private Placement [Member]
Term loan two thousand and twenty two warrants.
2022 warrants
Term Loan Two Thousand and Twenty Two Warrants [Member]
Effective interest rate percentage
Debt Instrument, Interest Rate, Effective Percentage
Gain Loss From Lease Modification
Gain loss from lease modification.
Gain from lease modification
Preferred Stock, Shares Outstanding
Preferred stock, shares outstanding
Preferred Stock, Shares Outstanding, Beginning Balance
Preferred Stock, Shares Outstanding, Ending Balance
Investment, Name [Axis]
Investment, Name
Finance Lease, Liability, to be Paid, Year Two
2028
Fair Value, Recurring [Member]
Fair Value, Recurring [Member]
Number of customers
Number Of Customers
Number of customers.
Common Stock, Shares, Issued
Balance (in shares)
Balance (in shares)
Common stock, shares issued
Number of common shares
Common Stock, Shares, Issued, Total
Segment Reporting [Line Items]
Plan Two [Member]
Plan two.
Plan 2
Contingent consideration liability
Contingent consideration
Contingent Consideration Liability, Total
Fair value of contingent consideration
Investment, Variable Interest Rate, Type [Extensible Enumeration]
Eligible Milestone Payments
Eligible milestone payments.
Eligible milestone payments payable
Income Tax Expense (Benefit)
Income Tax Expense (Benefit), Total
Income tax benefit (expense)
Income tax expense
Income tax benefit (expense)
Income tax benefit (expense)
Prepayment Occurs Prior to February 1, 2024
Debt Instrument Prepayment Occurring Prior to February One Two Thousand Twenty Four [Member]
Debt instrument prepayment occurring prior to february one two thousand twenty four.
Counterparty Name [Domain]
Counterparty Name
Accounts Receivable, net
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]
The authorized amount under a common stock sales agreement.
Common Stock Sales Agreement Authorized Amount
Common stock sales agreement, authorized amount
Common Stock And Warrents [Member]
Common stock and warrents member.
Common Stock and Warrents
Related Party Transaction [Line Items]
Related Party Transaction [Line Items]
Total
Inventory Current and Noncurrent
Inventory current and noncurrent.
Restricted Stock Units (RSUs) [Member]
Restricted Stock Units
Restricted Stock Units
AXS-05
AXS-05 [Member]
AXS-05 .
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Common stock to be issued if warrants are exercised (in shares)
Debt instruments maturity, month and year.
Debt Instruments Maturity Month And Year
Debt instrument maturity, month and year
Represents about term loan tranche one.
Term Loan2020 Tranche One [Member]
Term loan 2020 tranche one
2020 Warrants
Line of Credit Facility, Maximum Borrowing Capacity
Maximum loan amount
Term loan advance
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Less imputed interest
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted-Average Remaining Contractual Term
Weighted average contractual term
Finance lease, lease terms
Lessee, Finance Lease, Term of Contract
Leerink
Leerink.
Leerink [Member]
Trade Receivables
Trade Receivables.
Trade receivables
Probability weighted income approach
Valuation, Income Approach [Member]
Term Loans [Member]
Term loans.
Term Loans
General and Administrative Expense
General and Administrative Expense, Total
General and administrative expense (excluding share-based compensation expense)
Income Statement [Abstract]
Prepayment Occurs On or After February 1, 2024 but Prior to February 1, 2025
Debt Instrument Prepayment Occurring On or After February One Two Thousand Twenty Four But Prior to February One Two Thousand Twenty Five [Member]
Debt instrument prepayment occurring on or after february one two thousand twenty four but prior to february one two thousand twenty five.
Decrease in operating lease liability due to lease modification
Decrease In Operating Lease Liability Due To Lease Modification
Decrease in operating lease liability due to lease modification.
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Number of shares, Forfeited
Lease, Cost [Table Text Block]
Schedule of Lease Expense
Susan Mahony [Member]
Susan Mahony.
Susan Mahony
Line of Credit Facility Expiration Date2
Line of Credit Facility Expiration Date2
Expiry Date
The final payment fee at extinguishment of debt.
Extinguishment Of Debt Fee Amount
Final payment fee
Related and Nonrelated Parties [Domain]
Related Party
Net loss per common share, basic
Earnings Per Share, Basic
Earnings Per Share, Basic, Total
Contingent consideration
Contingent Consideration [Member]
Contingent consideration [Member].
Percentage of manufacturer discounts during the catastrophic coverage phase
Percentage of Manufacturer Discounts During the Catastrophic Coverage Phase
Percentage of manufacturer discounts during the catastrophic coverage phase.
Document Period End Date
Document Period End Date
Intangible Asset, Finite-Lived, Estimated Amortization Expense, Remainder of Fiscal Year
2026
Finance Lease, Interest Expense
Interest on lease liabilities
Third amendment to loan and security agreement.
Third Amendment To Loan and Security Agreement
Third Amendment To Loan and Security Agreement [Member]
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Accrued Expenses and Other Current Liabilities
Total
Intangible Asset, Finite-Lived, after Accumulated Amortization
Finite-Lived Intangible Assets, Net, Ending Balance
Finite-Lived Intangible Assets, Net, Beginning Balance
Net carrying amount
The amount of future payments payable under the collaboration arrangement.
Collaboration Arrangement Future Potential Payments
Future milestone payments
The minimum amount of market capital to be maintained under debt instruments.
Long Term Debt Additional Drawn Covenant Minimum Market Capitalization Amount
Minimum amount of market capital to be maintained
Cost of revenue (excluding amortization and depreciation)
Cost of product sales (excluding amortization and depreciation)
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization
Purchases of equipment
Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Property, Plant, and Equipment, Total
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Weighted average exercise price, Granted
Sharebased compensation arrangement by sharebased payment award other than option lapsed intrinsic value.
Sharebased Compensation Arrangement by Sharebased Payment Award Other than Option Lapsed Intrinsic Value
Intrinsic value lapsed
Common Stock, Shares Authorized
Common stock, shares authorized
Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Two
2028
Potential Material Losses From Claims
Potential material losses from claims.
Potential material losses from claims
Statement of Stockholders' Equity [Abstract]
Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block]
Schedule of PSU Activity
Finance Lease, Right-of-Use Asset, after Accumulated Amortization, Total
Finance Lease, Right-of-Use Asset, after Accumulated Amortization
Finance lease, right-of-use asset
Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]
Operating Lease
Prepaid Expense and Other Assets, Current
Prepaid and other current assets
Foreign Currency Transactions and Translations Policy [Policy Text Block]
Foreign Currency Translation
if prime rate is greater than or equal to seven point zero zero percent, the greater of either [Member]
if prime rate is greater than or equal to 7.00%, the greater of either.
If Prime Rate Is Greater Than Or Equal To 7.00%, The Greater of Either [Member]
Minimum different from remaining percentage of cash flow
Long Term Debt Different From Remaining Drawn Covenant Minimum Cash Flow Percentage
Long term debt different from remaining drawn covenant minimum cash flow percentage.
Gain on lease modification
Gain On Lease Modification
Gain on lease modification.
Performance obligations
Payment terms
Revenue, Performance Obligation, Description of Payment Terms
Fourth amendment to loan and security agreement.
Fourth Amendment To Loan and Security Agreement [Member]
Fourth Amendment To Loan and Security Agreement
Debt Instrument, Interest Rate, Stated Percentage
Base interest rate
Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense [Table Text Block]
Schedule of Finite Lived Intangible Assets Future Amortization Expenses
Total operating expenses
Costs and Expenses
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Disaggregation of Revenue [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Aggregate intrinsic value, Outstanding
The fair value of outstanding warrants.
Fair Value Of Warrants
Fair value
Term Loan Advances Other Than Tranche 1A
Term Loan Advances Other Than Tranche One A [Member]
Term loan advances other than tranche one A.
Revenue milestones.
Revenue Milestones
Revenue milestones
Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent
Purchase price of common stock percent
Assets
Total assets
Title of 12(b) Security
Title of 12(b) Security
Goodwill, beginning balance
Goodwill, ending balance
Balance at December 31,2021
Goodwill
Goodwill, Total
Goodwill Remain Unchanged
Preferred Stock, Value, Issued
Preferred Stock, Value, Issued, Ending Balance
Preferred Stock, Value, Issued, Total
Preferred Stock, Value, Issued, Beginning Balance
Preferred stock, $0.0001 par value per share (10,000,000 shares authorized, none issued and outstanding)
Represents the prepayment of debt occurring prior to first anniversary of closing date.
Debt Instrument Prepayment Occurring Prior To First Anniversary Of Closing Date [Member]
Prepayment Occurs Prior to First Anniversary of Closing Date
Purchased of common stock
Payments for Repurchase of Common Stock
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Number of shares, Nonvested, ending balance
Number of shares, Nonvested, beginning balance
Stock Issued During Period, Value, Stock Options Exercised
Issuance of common stock upon exercise of options
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Schedule of Stock-Based Compensation Expense Recognized
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Number of shares, Granted
Finance Lease, Liability, to be Paid, Year Three
2029
Customer Concentration Risk [Member]
Customer Concentration Risk
Antidilutive Securities, Name
Antidilutive Securities, Name [Domain]
Liabilities:
Liabilities, Fair Value Disclosure [Abstract]
Intangible Assets [Abstract]
Intangible Assets Abstract.
Effective tax rate
Effective Income Tax Rate Reconciliation, Percent
Effective tax rate
Effective Income Tax Rate Reconciliation, Percent, Total
Effective tax rate
Change in fair value of contingent consideration
Change In Fair Value Of Contingent Considerations
Change in fair value of contingent considerations.
Adjustment to fair value
Gain in fair value of contingent consideration
Research and Development Arrangement, Contract to Perform for Others, Type [Domain]
Research and Development Arrangement, Contract to Perform for Others, Type
Variable Rate [Axis]
Variable Rate
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
2026
2026
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted average exercise price
Interest Paid, Excluding Capitalized Interest, Operating Activity
Interest paid
Product Sales
Product [Member]
Product Sales
Schedule of future minimum lease payments.
Schedule of Future Minimum Lease Payments [Table Text Block]
Schedule of Future Minimum Lease Payments of Leases
Lessee, Operating Lease, Liability, to be Paid, Year One
2027
Weighted average price at which warrants were issued.
Warrants Issued In Period Weighted Average Exercise Price
Issued
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability
Finance lease right-of-use asset obtained in exchange for finance lease liability
Finance lease right-of-use asset recognized during period
Prior period adjustments for product sales resulting from changes in estimates
Prior Period Adjustments For Product Sales Resulting From Changes in Estimates
Prior period adjustments for product sales resulting from changes in estimates.
Available Term Loan Commitment Amount
Available term loan commitment amount.
Available Term Loan Commitment Amount
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term
Weighted average contractual term, Outstanding
Schedule of Disaggregation of Product Sales
Disaggregation of Revenue [Table Text Block]
Segment Reporting [Table Text Block]
Schedule of the reportable segment and includes the reconciliation to consolidated net loss
Stock Issued During Period Value Stock Options And Employee Stock Purchase Plan Exercised
Stock issued during period value stock options and employee stock purchase plan exercised.
Issuance of common stock upon exercise of options and under employee stock purchase plan
Senior Secured Term Loan [Member]
Senior secured term loan.
Senior Secured Term Loan
Increase (Decrease) in Operating Lease Liability
Operating lease liability
Blackstone Securities Purchase Agreement
Blackstone Securities Purchase Agreement [Member]
Blackstone securities purchase agreement.
Cash
Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Four
2030
Equity, Attributable to Parent
Ending balance
Beginning balance
Total stockholders’ equity
Valuation Approach and Technique [Domain]
Underwriting discounts and commissions.
Underwriting Discounts And Commissions
Underwriting discounts and commissions
Entity Address, Address Line Two
Entity Address, Address Line Two
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Collaborative Arrangement and Arrangement Other than Collaborative
Income Taxes
Income Tax Disclosure [Text Block]
Senior Secured Term Toan Available Until May 31, 2027 [Member]
Senior secured term toan available until May 31, 2027.
Senior Secured Term Toan Available Until May 31, 2027
Earnings Per Share [Text Block]
Net Loss per Common Share
Finance Lease Liability Recognized in Exchange of Right of Use Asset
Finance lease liability recognized in exchange of right of use asset.
Finance lease liability recognized during period
Fifth Amendment To Loan And Security Agreement
Fifth Amendment To Loan And Security Agreement [Member]
Fifth amendment to loan and security agreement member.
Cash Equivalents, at Carrying Value [Abstract]
Cash Equivalents
Other offering costs.
Other Offering Costs
Other offering costs
Number of Reportable Segments
Number of reportable segment
Sales
Revenue Benchmark [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted average grant date fair value
The commission percentage paid under a common stock sales agreement.
Common Stock Sales Agreement Commission Percentage
Common stock sales agreement, commission percentage
The entire disclosure for license agreements.
License Agreements Disclosure [Text Block]
License Agreements
Plan One [Member]
Plan one.
Plan 1
Long-Term Debt, Total
Long-Term Debt
Tranche Commitment
Tranche Commitment
Credit Facility [Axis]
Share based compensation arrangement by share based payment award options expired in period.
Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period
Number of shares, Expired
Finance Lease, Liability, Undiscounted Excess Amount
Less imputed interest
Line of Credit, Current
Repayments of Long-Term Debt
Repayments of Long-Term Debt, Total
Repayment of debt
Inventory, Policy [Policy Text Block]
Inventory
Represents the number of financial institutions holding the Company's cash.
Number Of Financial Institutions Holding Deposits
Number of financial institutions that hold the Company's cash
Issuance of common stock upon financing
Stock Issued During Period Value Financing
Value of stock issued pursuant to a financing arrangement during the period.
Revolving Facilities
Revolving Credit Facility [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Weighted average grant date fair value, Vested
Intangible Asset
Intangible Asset [Text Block]
Geographical [Domain]
Information pertaining to Pfizer, Inc.
Pfizer Inc [Member]
Pfizer Inc
Number of Asian markets.
Number of Asian Markets
Number of Asian markets
Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Three
2029
Schedule of Maturities of Long-Term Debt [Table Text Block]
Schedule of Principal Payments
Statistical Measurement [Axis]
Statistical Measurement
Mark Jacobson
Mark Jacobson [Member]
Mark Jacobson.
Stock-Based Compensation
Share-Based Payment Arrangement [Policy Text Block]
Stock Based Compensation
Money Market Funds
Money Market Funds [Member]
Advertising Costs
Advertising Cost [Policy Text Block]
Entity Interactive Data Current
Entity Interactive Data Current
Debt Instrument, Additional Bear Interest Rate, Percentage
Debt instrument, additional bear interest rate, percentage.
Additional bear interest rate percentage
Gain (Loss) on Extinguishment of Debt
Gain (Loss) on Extinguishment of Debt, Total
Loss on debt extinguishment
Loss on debt extinguishment
Lessee, Operating Lease, Liability, to be Paid, Year Three
2029
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Milestone payments
Milestone Payments
Milestone payments.
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term
Weighted average contractual term, Vested and expected to vest
Common Stock, Value, Issued
Value of common stock
Common Stock, Value, Issued, Total
Common Stock, Value, Issued, Beginning Balance
Common Stock, Value, Issued, Ending Balance
Common stock, $0.0001 par value per share (150,000,000 shares authorized, 52,299,889 and 50,882,766 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively)
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Computation of Basic and Diluted Net Loss per Common Share
Segment Reporting, Descriptive Information [Abstract]
Segment and Geographic Information
Taxes Payable, Current, Total
Taxes Payable, Current
Accrued taxes
Equipment, net
Property, Plant, and Equipment [Policy Text Block]
Equipment, net
Royalty Expense
Milestone payments or royalties
Royalty expense
Raw materials
Inventory, Raw Materials, Gross
Liabilities
Total liabilities
Term Loan Available Until May 31, 2027 [Member]
Term loan available until May 31, 2027.
Term Loan Available Until May 31, 2027
Cost of product sales
Cost of product sales
Cost of Revenue
Cost of Revenue, Total
Business Combination [Text Block]
Acquisitions
Schedule of fair value of financial instruments measured on a recurring basis
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Product and Service [Axis]
Product and Service
Retained Earnings (Accumulated Deficit)
Accumulated deficit
Accumulated deficit
Retained Earnings (Accumulated Deficit), Total
Retained Earnings (Accumulated Deficit), Beginning Balance
Retained Earnings (Accumulated Deficit), Ending Balance
Level 3
Fair Value, Inputs, Level 3 [Member]
Carrying value as of the balance sheet date of obligations incurred through that date and payable for research and development. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Accrued Research And Development Current
Accrued research and development
Cash and cash equivalents
Cash and Cash Equivalents, Fair Value Disclosure
Increase (Decrease) in Accounts Payable
Accounts payable
Increase (Decrease) in Accounts Payable, Total
License Agreements
License Agreements [Policy Text Block]
License Agreements.
Expected cash dividend
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Payments
Auvelity
Auvelity [Member]
Auvelity.
AUVELITY
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Research And Development Arrangement Contract To Perform For Others [Line Items]
Revenues [Abstract]
Share Price
Share Price
Share price
Fair Value, by Balance Sheet Grouping [Table]
First Lien Senior Secured Term Loan [Member]
First lien senior secured term loan.
First Lien Senior Secured Term Loan
Disaggregation of Revenue [Line Items]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Nature of Business and Basis of Presentation
Fair Value Measurement Inputs and Valuation Techniques [Table]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Table]
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]
Changes in operating assets and liabilities:
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
Schedule of Warrant Activity
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
Vesting period
Stock Issued During Period, Shares, New Issues
Shares issued
Fair Value Measurement Inputs and Valuation Techniques [Abstract]
Class of Warrant or Right, Outstanding
Warrants outstanding beginning balance
Warrants outstanding ending balance
Warrants outstanding
Non-current inventory and other assets
Non Current Inventory and Other Assets
Non-current inventory and other assets
Variable Rate [Domain]
Variable Rate
Intangible Asset, Finite-Lived, Accumulated Amortization
Accumulated amortization
Less: accumulated amortization
Accumulated amortization
Customer Two
Customer Two [Member]
Customer Two.
Accounting policies.
Accounting Policies [Table]
Accounting Policies [Table]
Represents the information if the outstanding principle and advances under loan agreement exceeds fifty five million.
Outstanding Advances Under Loan Agreement Equals Or Exceeds Sixty Five Million [Member]
Outstanding principle and advances under the loans agreement exceeds 65 million
Related Party Transactions [Abstract]
Operating Lease, Cost
Total operating lease expense
Operating lease expense
Royalty revenue
Royalty Revenue
Royalty Revenue
Long-Lived Asset, Class [Axis]
Debt Instrument, Bear Interest Rate, Percentage
Debt instrument, bear interest rate, percentage.
Bear interest rate percentage
Income Tax, Policy [Policy Text Block]
Income Taxes
Long-Term Debt [Text Block]
Loan and Security Agreement
Fair Value Hierarchy and NAV [Axis]
Hercules Loan Agreement [Member]
Hercules loan agreement.
Hercules Loan Agreement
Assets:
Assets, Fair Value Disclosure [Abstract]
Development milestones.
Development Milestones
Development milestones
Reconciliation of net loss
Segment Reporting, Profit (Loss) [Abstract]
Herriot Tabuteau [Member]
Herriot Tabuteau.
Herriot Tabuteau
Remaining loan amount
Line of Credit Facility, Remaining Borrowing Capacity
Number of reporting units
Goodwill, Reporting Unit, Number
Cash paid for common stock issuance costs
Cash paid for common stock issuance costs
Payments of Stock Issuance Costs
Operating Lease, Liability, Current
Operating lease liability, current portion
Number of warrants (or share units) exercised during the current period.
Warrants Exercised In Period
Exercised
Warrants exercised
The increase (decrease) during the reporting period in the value of prepaid expenses and other current assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.
Increase Decrease In Prepaid Expense And Other Assets Current
Prepaid expenses and other current assets
2023 Warrants
Term Loan Two Thousand and Twenty Three Warrants [Member]
Term Loan Two Thousand and Twenty Three Warrants [Member]
Concentration Risk Type [Domain]
Lessee, Operating Lease, Existence of Option to Extend [true false]
Lessee, operating lease, existence of option to extend [true false]
Share-Based Compensation ArrangementAchievement Of Specified Performance Goals Include Achieving Revenue And Commercialization Targets Performance Period
Share-based compensation arrangement achievement of specified performance goals include achieving revenue and commercialization targets performance period.
Achievement of specified performance goals include achieving revenue and commercialization targets performance period
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Weighted average grant date fair value, Nonvested, beginning balance
Weighted average grant date fair value, Nonvested, ending balance
Accounting policies.
Accounting Policies [Line Items]
Accounting Policies [Line Items]
Customer [Domain]
Liabilities and Equity
Total liabilities and stockholders’ equity
Lessee, Operating Lease, Liability, to be Paid, Year Two
2028
Research and Development Expense
Research and development
Research and development expense recognized
Research and Development Expense, Total
Represents information pertaining to the 2015 Equity Compensation Plan.
Two Thousand Fifteen Equity Compensation Plan [Member]
2015 Plan
AXS-05.
Represents information pertaining to AXS-05.
Axs05 [Member]
AXS-05
Lessee, Lease, Description [Table]
Document Fiscal Period Focus
Document Fiscal Period Focus
Beneficial ownership percentage
Beneficial Ownership Percentage
Beneficial ownership percentage.
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest [Abstract]
Aggregate intrinsic value
Inventory, Noncurrent, Total
Inventory, Noncurrent
Non-current inventory and other assets
December two thousand nineteen sales agreement.
December Two Thousand Nineteen Sales Agreement [Member]
December 2019 Sales Agreement
Schedule of Inventory
Schedule of Inventory, Current [Table Text Block]
Research and Development Arrangement, Contract to Perform for Others, Type [Axis]
Research and Development Arrangement, Contract to Perform for Others, Type
Schedule of Inventory, Noncurrent [Table Text Block]
Summary of Balance Sheet Classification of Inventory
Accrued royalties
Accrued Royalties, Current
Performance Shares [Member]
Performance Stock Units
Contract with Customer, Liability [Abstract]
Line of Credit Facility, Current Borrowing Capacity
Jazz pharmaceuticals Plc.
Jazz Pharmaceuticals Plc [Member]
Jazz Pharmaceuticals Plc
Sale of Stock [Axis]
Sale of Stock
Royalty Agreements
Royalty Agreements Disclosure [Text Block]
Royalty agreements disclosure text block
Remaining Weighted-Average Useful Life
Intangible assets, Estimated period of benefit
Intangible Asset, Finite-Lived, Useful Life
Mark Coleman [Member]
Mark Coleman .
Mark Coleman
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Net decrease in cash
Entity Current Reporting Status
Entity Current Reporting Status
Use of Estimates, Policy [Policy Text Block]
Use of Estimates
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Number of shares, Exercisable
Non-refundable upfront payment received
upfront payment received
upfront payment received
Level 1
Fair Value, Inputs, Level 1 [Member]
Issuance of common stock upon exercise of warrants (in shares)
Stock Issued During Period Exercise Of Warrants
Stock issued during period exercise of warrants.
Net issuance of shares
Accounts Payable, Current
Accounts payable
Accounts Payable, Current, Total
Roger Jeffs [Member]
Roger jeffs.
Roger Jeffs
Project [Domain]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Schedule of Potentially Dilutive Securities
Incremental Term Loans [Member]
Incremental term loans.
Incremental Term Loans
Fair value price of a single share of a number of saleable stocks of a company
Share Price Fair Value
Fair value share price
Consolidated interest income
Interest Income, Operating
Interest Income, Operating, Total
Document Transition Report
Document Transition Report
Liability Class [Axis]
Commitments and Contingencies Disclosure [Abstract]
Inventories, net
Increase (Decrease) in Inventories
Increase (Decrease) in Inventories, Total
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
Accrued expenses and other current liabilities
Accounting Standards Update [Domain]
Payout Multiplier Ratio
Payout multiplier ratio.
Payout multiplier ratio
Liabilities, Current [Abstract]
Current liabilities:
Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount
Compensation cost not yet recognized related to nonvested RSUs
Common stock purchase price per share
Common Stock Purchase Price Per Share
Common stock purchase price per share.
Warrants and Rights Note Disclosure [Abstract]
WarrantsAndRightsNoteDisclosureAbstract
Net equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
Stock Issued During Period Value New Issues Net
Proceeds from issuance of common stock, net
Stock vested during period value restricted common stock award.
Stock Vested During Period Value Restricted Common Stock Award
Issuance of common stock upon vesting of RSUs
Remaining Unamortized Balance of Deferred Assets
Remaining unamortized balance of deferred assets.
Remaining unamortized balance of deferred assets
Debt, Weighted Average Interest Rate
Weighted-average interest rate percentage
Common Stock [Member]
Common Stock
Recent Accounting Pronouncements
Accounting Standards Update and Change in Accounting Principle [Abstract]
Business Combination
Business Combination [Policy Text Block]
Accounting Standards Update [Axis]
Credit Facility [Domain]
Statistical Measurement
Statistical Measurement [Domain]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Gross carrying amount
Finite-Lived Intangible Assets, Gross, Total
Intangible Asset, Finite-Lived, before Accumulated Amortization
Gross carrying amount
Equity, Attributable to Parent [Abstract]
Stockholders’ equity:
Weighted average common shares outstanding, basic
Weighted Average Number of Shares Outstanding, Basic
Weighted Average Number of Shares Outstanding, Basic, Total
Cost of Revenue
Cost of Goods and Service [Policy Text Block]
Cost of Revenue
Equipment, net
Property, Plant, and Equipment [Abstract]
Equipment, net
Finance Lease, Liability, to be Paid, Remainder of Fiscal Year
2026
Assets [Abstract]
Assets
Entity Central Index Key
Entity Central Index Key
Antidilutive Securities [Axis]
Antidilutive Securities
Line of Credit Facility [Table]
Line Of Credit Facility [Table]
Mark Saad [Member]
Mark saad.
Mark Saad
Current Fiscal Year End Date
Current Fiscal Year End Date
Debt, Policy [Policy Text Block]
Debt Issuance Costs
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Number of shares
Document Quarterly Report
Document Quarterly Report
Line of Credit Facility, Increase (Decrease), Net
Line of Credit Facility, Increase (Decrease), Net, Total
Increased Loan Amount
Other development and sales based milestones recognized.
Other Development and Sales based Milestones Recognized
Other development and sales based milestones recognized
Long-Term Debt, Maturity, Remainder of Fiscal Year
2026
Level 2
Fair Value, Inputs, Level 2 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Weighted average exercise price, Outstanding, ending balance
Weighted average exercise price, Outstanding, beginning balance
Interest expense, net
Investment Income, Net
Investment Income, Net, Total
Interest expense, net
Interest expense, net
Business Combination
Business Combination [Abstract]
Research and Development Expense (Reversal)
Research and development expense (reversal).
Research and development expense (reversal) recognized
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Net cash used in operating activities
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Forty five day period after closing of fourth amendment to loan and security agreement.
Forty Five Day Period After Closing Of Fourth Amendment To Loan And Security Agreement [Member]
45-day Period after Closing of Fourth Amendment to Loan and Security Agreement
Net loss per common share, diluted
Earnings Per Share, Diluted
Earnings Per Share, Diluted, Total
The final payment fee to be paid under the debt arrangement as a percentage of aggregate amount of all term loan advances minus the aggregate amount of repayments made.
Debt Instrument Final Payment Fee Threshold Percentage Of Debt Outstanding
Percentage of final payment fee
Minimum product revenue percent
The minimum percentage of revenue should be achieved under the debt instrument.
Long Term Debt Additional Drawn Minimum Revenue Percent
Preferred Stock, Par or Stated Value Per Share
Preferred stock, par value
Operating Lease, Weighted Average Discount Rate, Percent
Operating lease, discount rate
Net loss
Net loss
Prepayment Occurs On or After February 1, 2025 but Prior to February 1, 2026
Debt Instrument Prepayment Occurring On or After February One Two Thousand Twenty Five But Prior to February One Two Thousand Twenty Six [Member]
Debt instrument prepayment occurring on or after february one two thousand twenty five but prior to february one two thousand twenty six.
Commitments and Contingencies Disclosure [Text Block]
Commitments and Contingencies
Accrued contingent consideration, current
Contingent consideration, current
Business Combination, Contingent Consideration, Liability, Current
Long-Lived Asset, Class [Domain]
Thereafter
Finite lived intangible assets amortization expense after year four.
Finite Lived Intangible Assets Amortization Expense After Year Four
Less: Reserves for Variable Consideration
Reserves for Variable Consideration
Reserves for Variable Consideration.
Less: Reserves for variable consideration
Effective Income Tax Rate Reconciliation, Percent [Abstract]
Income Taxes
Finance lease, liability, to be paid, after year four.
Finance Lease, Liability, to Be Paid, After Year Four
Thereafter
Contingent consideration liability, non-current
Contingent consideration, non-current
Business Combination, Contingent Consideration, Liability, Noncurrent
Measurement Frequency [Domain]
Tranches expire undrawn
Undrawn Expire Tranches
Undrawn expire tranches.
Scenario [Domain]
Scenario
Accounts receivable, Allowance for credit loss
Accounts Receivable, Allowance for Credit Loss
Accounts Receivable, Allowance for Credit Loss, Ending Balance
Accounts Receivable, Allowance for Credit Loss, Beginning Balance
Equity Components [Axis]
Equity Components
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]
Cash flows from investing activities
Statement of Cash Flows [Abstract]
Stock vested during period shares restricted common stock award.
Stock Vested During Period Shares Restricted Common Stock Award
Issuance of common stock upon vesting of RSUs (in shares)
Represents the number of votes per share each holder of shares is entitled to.
Equity Instrument Voting Rights Per Share
Common stock, voting right per share
Fair Value Hierarchy and NAV [Domain]
Income Tax Disclosure [Abstract]
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Weighted average exercise price, Exercised
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Weighted average grant date fair value
Revenue Recognition
Revenue [Policy Text Block]
Net Book Value at March 31, 2023
Balance at December 31, 2022
Intangible asset, net
Intangible Asset, Excluding Goodwill, after Accumulated Amortization
Net carrying amount
Net carrying amount
Accumulated Amortization
Fair Value of Financial Instruments
Fair Value Disclosures [Text Block]
Hunter Murdock
Hunter Murdock [Member]
Hunter Murdock.
Permitted Indebtedness Amount
Permitted indebtedness amount.
Permitted Indebtedness Amount
Finance Lease, Liability, Noncurrent
Finance lease liability, long-term
The minimum percentage of cash to be maintained under debt instruments.
Long Term Debt Additional Drawn Covenant Minimum Cash To Be Maintained As Security Percent
Minimum percentage of cash to be maintained as a security
Accounting Standards Update 2023-09 [Member]
ASU 2023-09
Chief Executive Officer [Member]
Dr. Tabuteau
Preferred Stock, Shares Authorized
Preferred stock, shares authorized
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements
Payments
Blackstone Loan Agreement [Member]
Blackstone loan agreement.
Blackstone Loan Agreement
SVB Securities Limited Liability Company.
SVB Securities Limited Liability Company [Member]
SVB Securities
Antidilutive securities
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Antidilutive securities
Unrecognized tax benefits
Unrecognized Tax Benefits that Would Impact Effective Tax Rate
Counterparty Name [Axis]
Counterparty Name
Class of Warrant or Right [Line Items]
Class of Warrant or Right [Line Items]
Number of Operating Segments
Number of operating segments
Accrued Liabilities and Other Liabilities [Abstract]
Term Loan Advances
Term Loan Advances [Member]
Term loan advances.
Project [Axis]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Shares available for future grant
Operating lease, expiration month and year.
Operating Lease Expiration Month And Year
Operating lease, expiration month and year
Balipodect
Balipodect [Member]
Balipodect.
Lessee operating lease liability payments due after year four.
Lessee Operating Lease Liability Payments Due After Year Four
Thereafter
Inventories, net
Inventory, Net
Inventories, net
Royalty Agreements [Abstract]
Royalty agreements.
Segment Reporting, Policy [Policy Text Block]
Segment Information
Outside of the United States
Non-US [Member]
Ex-U.S. Market Sales
Initial Cash Payment Per Collaboration Agreement.
Initial Cash Payment Per Collaboration Agreement
Upfront cash payment
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]
Concentration Risk Benchmark [Domain]
Represents the maximum reduction percentage of the royalty due as a result of required payments to third parties.
License Agreement Royalty Due Maximum Reduction Percentage As Result Of Required Payments To Third Parties
License agreement royalty, maximum reduction percent as a result of required third party payments
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Weighted average exercise price, Forfeited
Lessee, Operating Lease, Description
Lessee, operating lease, description
Term Loan Available Until May 31, 2026
Term Loan Available Until May 31, 2026 [Member]
Term loan available until May 31, 2026.
Contract With Customer Liability [Line Items]
Contract With Customer Liability [Line Items]
Contract with customer liability.
Other Research and Development Expense
Other research and development
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Number of shares, Outstanding, ending balance
Number of shares, Outstanding, beginning balance
Non-current Inventory and Other Assets
Non-current inventory and other assets.
Non-current inventory and other assets
Long-Term Debt, Current Maturities
Long-Term Debt, Current Maturities, Total
Short-term borrowings
Customer [Axis]
Measurement Input Discount Rate
Measurement Input, Discount Rate [Member]
Work in process
Inventory, Work in Process, Gross
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares
Non-vested options outstanding
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Beginning Balance
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Ending Balance
Research and Development Expense, Policy [Policy Text Block]
Research and Development Costs
Document Type
Document Type
Cash and Cash Equivalents, Policy [Policy Text Block]
Cash and Cash Equivalents
Weighted average price at which warrants were exercised.
Warrants Exercised In Period Weighted Average Exercise Price
Exercised
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Cash flows from operating activities
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]
Segment reporting, CODM, Individual title and position or group name [Extensible Enumeration]
Liabilities and Equity [Abstract]
Liabilities and stockholders’ equity
Lessee, Lease, Description [Line Items]
Stock Options
Period during which warrants are active, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Class Of Warrant Or Right Term
Term of warrants (in years)
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]
Loss from operations
Operating Income (Loss)
Loss from operations
Lender Name [Axis]
Lender Name
Segment Reporting [Table]
Selling and Marketing Expense
Selling and Marketing Expense, Total
Selling and marketing expense (excluding stock-based compensation expense)
Asset Class [Domain]
Securities Act File Number
Entity File Number
Finished goods
Inventory, Finished Goods, Gross
Revenues
Revenue from Contract with Customer [Text Block]
Immaterial effect
Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]
Weighted average exercise price, Forfeited/Canceled
Share-based compensation arrangement by share-based payment award options forfeitures or canceled in period, weighted average exercise price.
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures Or Canceled in Period, Weighted Average Exercise Price
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]
Schedule of Future Minimum Lease Payments of Leases
Adjustments to Additional paid-in capital Shares tendered for withholding taxes.
Adjustments To Additional Paid In Capital Shares Tendered For Withholding Taxes
Shares tendered for withholding taxes
Location, Statement of Income, Balance [Axis]
Retained Earnings [Member]
Accumulated Deficit
Interest Payable, Current
Accrued interest
Entity Registrant Name
Entity Registrant Name
Accounting Policies [Abstract]
Depreciation
Depreciation
Depreciation, Total
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Net loss
Segment net loss
Selling, general and administrative
Selling, General and Administrative Expense
Selling, General and Administrative Expense, Total
Percentage Of Facility Fee To Be Paid
Percentage of facility fee to be paid
Percentage of facility fee to be paid.
Lessee, Operating Lease, Renewal Term
Operating lease, renewal term
Schedule of interest expense and amortization of final payment fee, amortization of debt discount related to issuance costs and warrants.
Schedule of Interest Expense and Amortization of Final Payment Fee, Amortization of Debt Discount Related to Issuance Costs and Warrants [Table Text Block]
Schedule of Interest Expense and Amortization of Final Payment Fee, and Amortization of Debt Discount Related to Issuance Costs and Warrants
Accrued selling, general and administrative
Accrued Selling, General and Administrative Current
Accrued selling, general and administrative current.
Entity Address, Address Line One
Entity Address, Address Line One
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Weighted average contractual term
Takeda Pharmaceutical Company Limited [Member]
Takeda Pharmaceutical Company Limited.
Takeda Pharmaceutical Company Limited
Expiration date
Line of Credit Facility, Expiration Date
United States
UNITED STATES
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Issuance of common stock upon exercise of options (in shares)
Number of shares, Exercised
December two thousand nineteen and march two thousand twenty two sales agreement.
December Two Thousand Nineteen and March Two Thousand Twenty Two Sales Agreement [Member]
December 2019 and March 2022 Sales Agreement
Contingent consideration, measurement input
Business Combination, Contingent Consideration, Liability, Measurement Input
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Weighted average exercise price, Exercisable
Total current assets
Assets, Current
Fair Value, Recurring and Nonrecurring [Table]
Minimum liquidity covenant value
Debt Instrument Minimum Liquidity Covenant Value
Debt instrument minimum liquidity covenant value.
Earnings Per Share, Policy [Policy Text Block]
Basic and Diluted Net Loss per Common Share
Loss Contingencies [Line Items]
Loss Contingencies [Line Items]
Supplemental Cash Flow Information [Abstract]
Supplemental disclosures of cash flow information:
Related Party Transactions Disclosure [Text Block]
Related Party Transactions
Schedule of Accounts Receivable, Net
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]
Entity Small Business
Entity Small Business
Long-Term Debt, Excluding Current Maturities
Loan payable, long-term
Loan payable, long-term
Research and Development [Abstract]
License Agreements
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Aggregate intrinsic value, Vested and expected to vest
Term Loan 2020
Represents about term loan two thousand twenty.
Term Loan2020 [Member]
Investment, Name [Domain]
Investment, Name
Available and Undrawn Credit Facility Amount
Available and undrawn credit facility amount.
Available And Undrawn Credit Facility Amount
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Unrecognized compensation cost related to unvested stock options expected to be recognized
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Weighted average grant date fair value, Forfeited
Long-Term Debt, Type [Axis]
Long-Term Debt, Type
Significant Accounting Policies [Text Block]
Summary of Significant Accounting Policies
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
Weighted average exercise price, Expired
Accounts Receivables, net
Accounts Receivable, after Allowance for Credit Loss, Current
Accounts receivable, net
Accounts receivable, net
Change in Accounting Principle, Accounting Standards Update, Adoption Date
Adoption date
Accrued compensation
Employee-related Liabilities, Current
Employee-related Liabilities, Current, Total
Schedule of Long-Term Debt Instruments [Table Text Block]
Schedule of Outstanding Debt and Unamortized Debt Discount Balances
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Finance Lease, Liability, to be Paid, Year Four
2030
Earnings Per Share [Abstract]
Performance Stock Units [Member]
Performance Stock Units Member.
Performance Stock Units
Summary of Stock Option Activity
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Represents the number of license agreements the Company has entered into.
Number Of License Agreements
Number of exclusive license agreements
Lessee, Operating Lease, Liability, to be Paid, Year Four
2030
Plan Name [Axis]
Plan Name
Equity [Abstract]
Product and Service [Domain]
Product and Service
Class of Warrant or Right [Table]
Class Of Warrant Or Right [Table]
Equity [Text Block]
Stockholders' Equity
Measurement Frequency [Axis]
License agreement royalty as a percent of net sale
Represents the percentage of net sales of products containing the licensed products, due to licensor as a royalty.
License Agreement Royalty Due Percentage Of Net Sales
License agreement royalty as a percent of net sales
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]
Cash flows from financing activities
Amortization of debt discount related issuance costs and warrants
Amortization of Debt Discount (Premium)
Amortization of debt discount
Fair Value by Liability Class [Domain]
Line of Credit Facility, Lender [Domain]
Line of Credit Facility, Lender
TwoThousandTwentyFiveLongTermIncentivePlan [Member]
Two thousand twenty five long term incentive plan.
2025 Plan
Entity Tax Identification Number
Entity Tax Identification Number
Number of shares of stock issued during the period pursuant to a financing arrangement.
Stock Issued During Period Shares Financing
Issuance of common stock upon financing (in shares)
Issuance of common stock
Valuation Approach and Technique [Axis]
Payment Of Contingent Consideration
Payment of contingent consideration
Payment of contingent consideration
Accounts Receivable, net
Accounts Receivable [Policy Text Block]
Equity Component [Domain]
Equity Component
Entity Address, City or Town
Entity Address, City or Town
Symbravo.
Symbravo
Symbravo
Eligible to receive sales-based and other milestones
Eligible to receive sales-based and other milestones
Eligible to receive sales-based and other milestones
Business Combination [Axis]
Measurement Input Type [Domain]
Measurement Input Type
Long-Term Debt, Maturity, Year One
2027
Stock Issued During Period, Value, New Issues
Proceeds from issuance of common stock, gross
Issuance of common stock
Represents the information pertaining to AXS-05 and AXS-07.
Axs05 And Axs07 [Member]
AXS-05 and AXS-07
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Concentration Risk Type [Axis]
Inventory Write-down
Inventory write down
Finance lease costs.
Finance Lease Costs [Abstract]
Finance lease expense:
Lessee, Finance Lease, Renewal Term
Finance lease, renewal term
Antidilutive Security, Excluded EPS Calculation [Table]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Lessee, Operating Lease, Option to Extend
Lessee, operating lease, option to extend
Proceeds from draw down of debt
Proceeds from Long-Term Lines of Credit
Threshold period of specified consecutive trading days within which the volume weighted average price of company's common stock.
Class Of Warrants Or Rights Weighted Average Price Trading Days
Trading days
Statement [Table]
Statement [Table]
Sunosi.
Sunosi [Member]
Sunosi
SUNOSI
Royalty Revenue
Royalty [Member]
Share-Based Payment Arrangement, Expense
Stock-based compensation expense
Expense
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Loss before income taxes
Loss before income taxes
Antecip.
Affiliated Entity [Member]
Antecip
Entity Shell Company
Entity Shell Company
Accounts Payable and Other Accrued Liabilities, Current
Accrued expenses and other current liabilities
Total
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Net cash used in investing activities
Statement [Line Items]
Statement [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Leased office space.
Leased Office Space [Member]
22 Cortlandt Street Lease
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Number of shares, Vested
Number of shares, Vested
Maximum
Maximum
Percentage of manufacturer discounts during the initial coverage phase
Percentage of Manufacturer Discounts During the Initial Coverage Phase
Percentage of manufacturer discounts during the initial coverage phase.
Debt Disclosure [Abstract]
Finance Lease, Liability, to be Paid
Total lease payments
Sale of Stock [Domain]
Sale of Stock
Decrease in operating lease right-of-use asset due to lease modification
Decrease In Operating Lease Right-of-use Asset Due To Lease Modification
Decrease in operating lease right-of-use asset due to lease modification.
Ari Maizel [Member]
Ari Maizel.
Ari Maizel
Adjustments and reconciling items
Adjustments and Reconciling Items
Adjustments and reconciling items.
Maximum Revolving Credit Commitment Amount
Maximum revolving credit commitment amount.
Maximum revolving credit commitment amount
Share-Based Compensation Arrangement Achievement Of Specified Performance Goals Include Achieving Revenue Clinical Regulatory Targets Performance Period
Share-based compensation arrangement achievement of specified performance goals include achieving revenue clinical regulatory targets performance period.
Achievement of specified performance goals include achieving revenue, clinical regulatory targets performance period
Long Term Debt Maturities Repayments Of Principal After Year Four
Long-term debt maturities repayments of principal after year four.
Thereafter
Business Combination [Domain]
Concentration Risk Benchmark [Axis]
Debt Instrument, Redemption, Period [Domain]
Contingent Consideration
Commitments and Contingencies, Policy [Policy Text Block]
Asset Class [Axis]
Risks and Uncertainties [Abstract]
Concentration of Credit Risk
Payment, Tax Withholding, Share-Based Payment Arrangement
Payments of tax withholdings on stock awards
Payments of tax withholdings on stock award
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Weighted average grant date fair value, Granted
Amortization of final payment fee
Amortization of Debt Issuance Costs
Amortization of debt issuance costs
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Noncash Item [Abstract]
Adjustments to reconcile net loss to net cash used in operating activities:
The minimum percentage of cash to be maintained as security following the market capitalization conditions under the debt instruments.
Long Term Debt Additional Drawn Covenant Minimum Cash To Be Maintained As Security With Market Capitalization Covenant Percent
Minimum percentage of cash to be maintained as a security following market capitalization condition
First Amendment [Member]
First amendment.
First Amendment
Assets, Current [Abstract]
Current assets:
Finance Lease, Liability, Current
Finance lease liability, current
Leases [Abstract]
Leases
Document Fiscal Year Focus
Document Fiscal Year Focus
Common Stock, Shares, Outstanding, Ending Balance
Common Stock, Shares, Outstanding
Common stock, shares outstanding
Common Stock, Shares, Outstanding, Beginning Balance
Prime Rate [Member]
Prime Rate
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
Aggregate intrinsic value, Exercisable
Business Combination [Line Items]
Senior Secured Term Toan Available Until May 31, 2026 [Member]
Senior secured term toan available until May 31, 2026.
Senior Secured Term Toan Available Until May 31, 2026
Business Combination, Consideration Transferred
Business Combination, Consideration Transferred, Total
Business acquisition consideration
Revenue Discount rate
Measurement Input, Revenue Multiple [Member]
Forecast [Member]
Scenario Forecast
Sublease agreement term.
Sublease Agreement Term
Sublease agreement term
Secured Overnight Financing Rate (SOFR) [Member]
Secured Overnight Financing Rate
Change in Accounting Principle, Accounting Standards Update, Adopted [true false]
Adopted
Operating Lease, Liability, Noncurrent
Operating lease liability, long-term
Represents the information if the outstanding principle and advances under loan agreement exceeds fifty five million.
Outstanding Advances Under Loan Agreement Equals Or Exceeds Fifty Five Million [Member]
Outstanding principle and advances under the loans agreement exceeds 55 million
Intangible Asset, Finite-Lived [Table Text Block]
Schedule of Carrying Amount of Intangible Asset
Lessee, Operating Lease, Liability, to be Paid
Total lease payments
Additional Paid in Capital, Common Stock, Ending Balance
Additional Paid in Capital, Common Stock
Additional paid-in capital
Additional Paid in Capital, Common Stock, Beginning Balance
Security Exchange Name
Security Exchange Name
Measurement Input Type [Axis]
Measurement Input Type
Finance Lease, Weighted Average Discount Rate, Percent
Weighted average discount rate
Nick Pizzie [Member]
Nick Pizzie.
Nick Pizzie
Related and Nonrelated Parties [Axis]
Related Party
Recent Accounting Pronouncements
New Accounting Pronouncements, Policy [Policy Text Block]
Debt Instrument, Redemption, Period Two [Member]
Option until May 31, 2027
Warrant [Member]
Warrants
Increase in minimum cash requirement amount
Long Term Debt Additional Drawn Covenant Minimum Cash
Long Term debt additional drawn covenant minimum cash.
Class of Warrant or Right, Exercise Price of Warrants or Rights
Weighted average exercise price, Ending balance
Weighted average exercise price, Beginning balance
Exercise price of warrants (in dollars per share)
Entity Address, State or Province
Entity Address, State or Province
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Expected vesting period for unvested share-based compensation
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]
Number of shares
Right-of-use asset - operating lease
Operating lease, right-of-use asset
Right-of-use asset
Other two products
Other Two Products [Member]
Other Two Products
Amendment Flag
Amendment Flag
Loss Contingencies [Table]
Loss Contingencies [Table]
Research and Development, Contract to Perform for Others [Table]
Schedule Of Research And Development Arrangement Contract To Perform For Others [Table]
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Operating lease right-of-use asset obtained in exchange for operating lease liability
Concentration risk, percentage
Concentration Risk, Percentage
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Debt Instrument [Axis]
Debt Instrument
Interest Expense, Debt, Excluding Amortization
Interest expense
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Cash at beginning of period
Cash at end of period
Solriamfetol [Member]
Solriamfetol.
Solriamfetol
City Area Code
City Area Code
Cost of Product Sales
Cost of Revenue [Abstract]
Change in operating lease liability.
Change In Operating Lease Liability
Change in operating lease liability
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]
Finance Lease
Proceeds from issuance of common stock upon financing
Proceeds from Issuance of Common Stock
Proceeds from Issuance of Common Stock
Accrued sales discounts, rebates and allowances
Accrued Sales Commission, Current
Operating expenses:
Operating Expenses [Abstract]
Disclosure of accounting policy for significant risks and uncertainties.
Significant Risks And Uncertainties Policy Policy [Text Block]
Significant Risks And Uncertainties
Significant Risks And Uncertainties
Inventory
Inventory Disclosure [Text Block]
Debt Instrument, Redemption, Period [Axis]
Customer One
Customer One [Member]
Customer One.
Permitted Indebtedness Increase Amount
Permitted Indebtedness Increase Amount
Permitted indebtedness increase amount.
Common Stock, Par or Stated Value Per Share
Common stock, par value
Finance Lease, Liability, to be Paid, Year One
2027
Two Thousand Twenty And Two Thousand Twenty Two Warrents[Member]
Two thousand twenty and two thousand twenty two warrents member.
2020 and 2022 Warrents
Operating Sub Lease commencement Month and Year.
Operating Sub Lease commencement Month and Year
Operating sub Lease commencement month and year
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted-Average Remaining Contractual Term
Weighted average contractual term, Exercisable
Lessee, Leases [Policy Text Block]
Leases
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Number of shares, Vested and expected to vest
Liabilities, Current
Total current liabilities
Number of warrants (or share units) issued during the current period.
Warrants Issued In Period
Number of warrants issued
Issued
Segment Information
Segment Reporting [Text Block]
If Prime Rate Is Less Than 7.00%
If prime rate is less than Seven point Zero Zero Percent [Member]
If prime rate is less than 7.00%.
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative
Long-Term Debt, Maturity, Year Four
2030
Advertising costs
Advertising Expense
Pharmanovia [Member]
Pharmanovia.
Pharmanovia
Trading Symbol
Trading Symbol
Debt Instrument, Unamortized Discount, Noncurrent
Less: unamortized debt discount, long-term
Finance Lease, Weighted Average Remaining Lease Term
Weighted average remaining lease term
Finance Lease, Right-of-Use Asset, Amortization
Right-of-use asset amortization for finance lease
Amortization of right-of-use assets
Geographical [Axis]
Fair Value Measurements
Fair Value Measurement, Policy [Policy Text Block]
Stock-based compensation expense capitalized
Share-Based Payment Arrangement, Amount Capitalized
Represents the consecutive number of trading days to determine the weighted average price per share of ordinary shares.
Consecutive Trading Days
Prior trading days
Number of shares, Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Entity Emerging Growth Company
Entity Emerging Growth Company
Additional Paid-in Capital [Member]
Additional Paid-in Capital
Accounts Receivable, net
Receivables [Abstract]
License Agreement Term
Period of time, after the first commercial sale of the applicable product, the license agreement is valid, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
License agreement term, from first commercial sale
Long-Term Debt, Gross
Total outstanding debt, long-term
Outstanding principal amounts
Total outstanding debt, long-term
Plan Name [Domain]
Plan Name
License Agreements
License Agreement Terms [Member]
License Agreement
Schedule of Interest and Amortization Expense for Final Payment Fee and Debt Discount [Table Text Block]
Schedule of interest and amortization expense for final payment fee and debt discount.
Schedule of debt approximates its fair value given its variable interest rate
Customer Three
Customer Three [Member]
Customer Three.
Revenue Recognition
Disaggregation of Revenue [Abstract]
Finance Lease, Liability, Total
Finance Lease, Liability
Finance lease liabilty
Present value of finance lease liabilities
Issuance of common stock upon exercise of options and under employee stock purchase plan (in shares)
Stock Issued During Period, Shares, Employee Stock Purchase Plans
Business Combination [Table]
Cover [Abstract]
Cover
Segment Reporting, Other Segment Item, Amount
Other segment items
Proceeds From Issuance Of Common Stock Upon Exercise Of Options And Under Employee Stock Purchase Plan
Proceeds from issuance of common stock upon exercise of options and under employee stock purchase plan.
Proceeds from issuance of common stock upon exercise of options and under employee stock purchase plan
Hercules Capital Inc.
Hercules Capital Inc [Member]
Hercules Capital Inc
Share Based Compensation Arrangement By Share-Based Payment Award, Options AndEmployee Stock Purchase Plan Exercises in Period
Share based compensation arrangement by share based payment award options and employee stock purchase plan exercises in period.
Issuance of common stock upon exercise of options and under employee stock purchase plan (in shares)
Royalty and Milestone Revenue [Member]
Royalty and Milestone Revenue.
Milestone Revenue
Royalty and Milestone Revenue
Schedule of fair value measurements of contingent consideration recurring include significant unobservable inputs
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
Operating Lease, Weighted Average Remaining Lease Term
Operating lease, remaining lease term
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]
Schedule of RSU Activity
AXS-12 [Member]
AXS-12 .
AXS-12
Revenue from Contract with Customer [Abstract]
Amortization of debt discount related issuance costs and warrants
Amortization of Debt Discount Related Issuance Costs and Warrants
Amortization of debt discount related issuance costs and warrants.
Long-Term Debt, Type [Domain]
Long term DebtType
Concentration of Risk
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Property, Plant, and Equipment, Useful Life
Estimated useful life
Amortization Expense
Intangible asset amortization
Amortization of intangible asset
Amortization expense
Share-Based Payment Arrangement, Noncash Expense
Stock-based compensation expense
Share-based Payment Arrangement, Noncash Expense, Total
AXS-07 [Member]
AXS-07.
AXS-07
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Schedule of changes in fair value of contingent consideration liabilities
March Two Thousand Twenty Two Sales Agreement [Member]
March Two Thousand Twenty Two Sales Agreement [Member]
March 2022 Sales Agreement
SalesRevenueProductLineMember
Revenue, Product and Service Benchmark [Member]
Represents the prepayment penalty percentage on principal amount of debt.
Debt Instrument Prepayment Penalty Percentage
Percentage of prepayment penalty
Fair Value Disclosures [Abstract]
Cash and Cash Equivalent
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value, Total
Cash and Cash Equivalents, at Carrying Value, Beginning Balance
Cash and Cash Equivalents, at Carrying Value, Ending Balance
The minimum amount of cash should be maintained as first priority security interest under the terms of debt instrument.
Long Term Debt Additional Drawn Covenant Minimum Cash As Security Interest
Minimum cash to be maintain as a first priority security interest
Payment of debt issuance costs
Payments of Debt Issuance Costs
Non-cash lease expense.
Non Cash Lease Expense
Non-cash lease expense
Employee Stock [Member]
Employee Stock Purchase Plan
ESPP
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Net cash provided by financing activities
Option untill May 31, 2026
Debt Instrument, Redemption, Period One [Member]
Fair value of contingent consideration
Beginning Balance
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Ending Balance (Level 3)
Cash Equivalents, at Carrying Value
Cash Equivalents
Cash Equivalents, at Carrying Value, Total
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Number of shares, Forfeited/Canceled
Entity Filer Category
Entity Filer Category
Debt Instrument, Name [Domain]
Debt Instrument, Name
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description
Segment reporting, CODM, profit (Loss) measure, how used, description
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Weighted average exercise price, Vested and expected to vest
Accounts receivable, net
Increase (Decrease) in Accounts Receivable
Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year One
2027
AXS-14
AXS-14.
AXS-14 [Member]
Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
Equipment, net
Property, Plant and Equipment, Net, Total
Property, Plant and Equipment, Net, Beginning Balance
Property, Plant and Equipment, Net, Ending Balance
Total product sales, net
Revenue from Contract with Customer, Excluding Assessed Tax, Total
Revenue
Revenue from Contract with Customer, Excluding Assessed Tax
Inventory Disclosure [Abstract]
June two thousand twenty three public offering.
June Two Thousand Twenty Three Public Offering [Member]
June 2023 Public Offering
Milestone Revenue [Member]
Milestone revenue.
Milestone Revenue
Segment Reporting [Abstract]
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
Schedule Of Loss Before Income Taxes Effective Income Tax Rate
Schedule of Loss Before Income Taxes and Effective Tax Rates
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Statement of Financial Position [Abstract]
Finance Lease, Principal Payments
Payments on principal portion of finance lease obligation
Local Phone Number
Local Phone Number